Xcytrin motexafin gadolinium: Interim Phase I data

Interim data from a dose-escalation, U.S. Phase I trial in about 25 patients showed that 5 of 9 evaluable patients receiving Xcytrin in combination with Taxotere docetaxel achieved a partial response...